Exploring the in vitro photodynamic properties of mitochondrial-targeting red- and near-infrared-absorbing γ-aminobutyric acid-modified squaraine dyes
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (86)
Show source-provided references
1. Photodynamic therapy review: principles, photosensitizers, applications, and future directions10.3390/pharmaceutics13091332 ↗
2. Photodynamic therapy: from the basics to the current progress of N-Heterocyclic-Bearing dyes as effective photosensitizers10.3390/molecules28135092 ↗
3. Photodynamic therapy combined with antifungal drugs against kerion: a report of six cases and literature review10.1016/j.pdpdt.2024.104039 ↗
4. A systematic review of photodynamic therapy as an antiviral treatment: potential guidance for dealing with SARS-CoV-210.1016/j.pdpdt.2021.102221 ↗
5. Covalent organic frameworks: advancing antimicrobial photodynamic therapy for next-generation treatments10.1016/j.ccr.2024.216424 ↗
6. Photodynamic therapy of cancer: an update
7. ‘Lights, squaraines, action!’ – the role of squaraine dyes in photodynamic therapy10.4155/fmc-2022-0112 ↗
8. Design and synthesis of photosensitizer-peptide conjugates for PDT
9. Peptide-substituted phthalocyanine photosensitizers: design, synthesis, photophysicochemical and photobiological studies10.1039/c6pp00231e ↗
10. New peptide-conjugated chlorin-type photosensitizer targeting Neuropilin-1 for anti-vascular targeted photodynamic therapy10.3390/ijms161024059 ↗
11. Comparative study of two poly(amino acid)-based photosensitizer-delivery systems for photodynamic therapy10.1016/j.ijbiomac.2020.12.019 ↗
12. Chlorin p 6 -Based water-soluble amino acid derivatives as potent photosensitizers for photodynamic therapy10.1021/acs.jmedchem.6b00352 ↗
13. Design and synthesis of novel water-soluble amino acid derivatives of chlorin p6 ethers as photosensitizer10.1016/j.cclet.2018.04.029 ↗
14. Design, synthesis and biological evaluation of novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy10.1016/j.ejmech.2020.112715 ↗
15. Arginine mediated photodynamic therapy with silicon(IV) phthalocyanine photosensitizers10.1016/j.pdpdt.2023.103667 ↗
16. Tyrosine conjugated zinc(II) phthalocyanine for photodynamic therapy: synthesis and photophysicochemical properties10.1016/j.jphotochem.2016.10.037 ↗
17. Discovery of an amino acid-modified near-infrared Aza-BODIPY photosensitizer as an immune initiator for potent photodynamic therapy in melanoma10.1021/acs.jmedchem.1c02154 ↗
18. Amino acid derivatives of pyropheophorbide-a ethers as photosensitizer: synthesis and photodynamic activity10.1016/j.cclet.2016.03.019 ↗
19. An updated review on pharmaceutical properties of gamma-aminobutyric acid10.3390/molecules24152678 ↗
20. Effects of germinated brown rice extracts with enhanced levels of GABA on cancer cell proliferation and apoptosis10.1089/109662004322984653 ↗
21. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma10.1093/carcin/bgn041 ↗
22. GABA functionalized gold, silver, and copper nanoparticles: synthesis, characterization and potential applications
23. Intracellular calcium-induced ROS generation promotes squaraine phototoxicity
24. Northiosquaraine-based nanoparticles for red-light-induced photodynamic therapy via singlet oxygen generation10.1021/acsanm.4c03580 ↗
25. Systematic structural modification of squaraine dye for near-infrared window one and two multiplexed in vivo imaging and photothermal therapy10.1021/acs.jmedchem.4c00601 ↗
26. Supramolecular H-Aggregates of squaraines with enhanced type I photosensitization for combined photodynamic and photothermal therapy10.1021/acsnano.4c07764 ↗
27. Squaraine-loaded mesoporous silica nanoparticles for antimicrobial Photodynamic Therapy against bacterial infection10.1016/j.micromeso.2024.113096 ↗
28. Host-guest supramolecular cubes: a versatile engineering system of squaraine and Cuburbit[8]uril for selective fluorescence imaging and enhanced photodynamic therapy in tumor cells10.1016/j.cej.2024.150979 ↗
29. Squaraine-containing polymeric nanoparticles enable photodynamic and photothermal therapy of cancer cells10.1016/j.dyepig.2024.112138 ↗
30. Poly Lactic-co-Glycolic acid (PLGA) loaded with a squaraine dye as photosensitizer for antimicrobial photodynamic therapy10.3390/polym16141962 ↗
31. Electrospun polycaprolactone membranes functionalized with nanochitin for enhanced bioactivity in localized cancer photodynamic therapy
32. Hafnium-based metal–organic framework nanosystems entrapping squaraines for efficient NIR-responsive photodynamic therapy10.1021/acsami.4c17018 ↗
33. Ritika. A brief review of the biological potential of indole derivatives10.1186/s43094-020-00141-y ↗
34. The importance of indole and azaindole scaffold in the development of antitumor agents10.1016/j.ejmech.2020.112506 ↗
35. Target-based anticancer indole derivatives and insight into structure‒activity relationship: a mechanistic review update (2018–2021)10.1016/j.apsb.2022.03.021 ↗
36. “From darkness to radiance”: light-induced type I and II ROS-mediated apoptosis for anticancer effects of dansylpiperazine-bearing squaraine dyes10.1016/j.bioorg.2025.108379 ↗
37. In vitro phototherapeutic effects of indolenine-based mono- and dithiosquaraine cyanine dyes against Caco-2 and HepG2 human cancer cell lines10.1016/j.pdpdt.2020.101844 ↗
38. Deep-tissue activation of photonanomedicines: an update and clinical perspectives10.3390/cancers14082004 ↗
39. Benz[e]indole-bearing aminosquaraine dyes: which of the amines introduced into the squaric ring will be able to induce the best in vitro photodynamic effect?10.1016/j.dyepig.2023.111239 ↗
40. Heptamethine cyanine-loaded nanomaterials for cancer immuno-Photothermal/Photodynamic therapy: a review10.3390/pharmaceutics14051015 ↗
41. New synthetic approach to aminosquarylium cyanine dyes
42. Synthesis and in vitro evaluation of the antitumoral phototherapeutic potential of squaraine cyanine dyes derived from indolenine10.1016/j.dyepig.2019.04.007 ↗
43. Photodynamic activity of indolenine-based aminosquaraine cyanine dyes: synthesis and in vitro photobiological evaluation10.1016/j.dyepig.2019.108024 ↗
44. Picolylamine-functionalized benz[e]indole squaraine dyes: synthetic approach, characterization and in vitro efficacy as potential anticancer phototherapeutic agents10.1016/j.ejmech.2021.114071 ↗
45. Photochemical properties of squarylium cyanine dyes10.1039/c3pp50132a ↗
46. Recent progress in utilizing near-infrared J-aggregates for imaging and cancer therapy10.1039/D0QM00557F ↗
47. An investigation of squaraines as a new class of fluorophores with long-wavelength excitation and emission10.1007/BF00862734 ↗
48. Red and near-infrared absorbing dicyanomethylene squaraine cyanine dyes: photophysicochemical properties and anti-tumor photosensitizing effects10.3390/ma13092083 ↗
49. Effect of bovine serum albumin on the photodynamic activity of sulfonated tetrapyrazinoporphyrazine10.1016/j.dyepig.2018.10.051 ↗
50. A squaraine dye for detection of HSA based on disassembling dimers to monomers10.1016/j.microc.2021.106172 ↗
51. D-(+)-Biotinylated squaraine dyes: a journey from synthetic conception, photophysical and -chemical characterization, to the exploration of their photoantitumoral action mechanisms10.1016/j.ejmech.2025.117699 ↗
52. Drug-like properties and the causes of poor solubility and poor permeability10.1016/S1056-8719(00)00107-6 ↗
53. Squaraine dyes: interaction with bovine serum albumin to investigate supramolecular adducts with aggregation‐induced emission (AIE) properties10.1002/asia.201900055 ↗
54. Site-selective interactions: squaraine dye−serum albumin complexes with enhanced fluorescence and triplet yields10.1021/jp100369x ↗
55. Evaluation of antifungal activity and potential application as fluorescent probes of indolenine and benzo[ E ] indole‐based squarylium dyes
56. In vitro and in silico evaluation of indole-bearing squaraine dyes as potential human serum albumin fluorescent probes10.3390/chemosensors10080314 ↗
57. Barbiturate squaraine dyes as fluorescent probes for serum albumins detection10.1016/j.jphotochem.2020.112710 ↗
58. Synthesis, characterization and protein-association of dicyanomethylene squaraine dyes10.1016/j.dyepig.2017.07.070 ↗
59. Light delivery over extended time periods enhances the effectiveness of photodynamic therapy10.1158/1078-0432.CCR-07-4705 ↗
60. Aminosquaraines as potential photodynamic agents: synthesis and evaluation of in vitro cytotoxicity10.1016/j.bmcl.2017.08.004 ↗
61. Krp1, a novel kelch related protein that is involved in pseudopod elongation in transformed cells10.1038/sj.onc.1203433 ↗
62. Classification of cell death: recommendations of the nomenclature committee on cell death 200910.1038/cdd.2008.150 ↗
63. Changes in actin and E-cadherin expression induced by 5-aminolevulinic acid photodynamic therapy in normal and Ras-transfected human mammary cell lines10.1016/j.jphotobiol.2011.10.002 ↗
64. Major determinants of photoinduced cell death: subcellular localization versus photosensitization efficiency10.1016/j.freeradbiomed.2011.05.023 ↗
65. Correlation between subcellular localization and photodynamic efficacy10.1142/S1088424604000374 ↗
66. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide‐ a derivatives
67. Squaraines bearing halogenated moieties as anticancer photosensitizers: synthesis, characterization and biological evaluation10.1016/j.ejmech.2016.02.035 ↗
68. Mitochondria as a therapeutic target for common pathologies10.1038/nrd.2018.174 ↗
69. Lysosomes as a therapeutic target10.1038/s41573-019-0036-1 ↗
70. Regulation of apoptosis by endoplasmic reticulum pathways10.1038/sj.onc.1207108 ↗
71. Endoplasmic reticulum-localized two-photon-absorbing boron dipyrromethenes as advanced photosensitizers for photodynamic therapy10.1021/acs.jmedchem.7b01907 ↗
72. Reactive oxygen species in cancer progression and its role in therapeutics10.37349/emed.2022.00073 ↗
73. Reactive oxygen species: not omnipresent but important in many locations10.3389/fcell.2021.716406 ↗
74. Type I and type II photosensitized oxidation reactions: guidelines and mechanistic pathways10.1111/php.12716 ↗
75. The concept and examples of type-III photosensitizers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
76. Hydrogen peroxide – production, fate and role in redox signaling of tumor cells10.1186/s12964-015-0118-6 ↗
77. Alkaline comet assay for assessing DNA damage in individual cells10.1002/0471140856.tx0312s65 ↗
78. The comet assay: topical issues10.1093/mutage/gem051 ↗
79. Measuring DNA modifications with the comet assay: a compendium of protocols10.1038/s41596-022-00754-y ↗
80. Analysis of apoptosis by propidium iodide staining and flow cytometry10.1038/nprot.2006.238 ↗
81. Synthesis and spectroscopic characterisation of N-Alkyl Quaternary ammonium salts typical precursors of cyanines10.3390/70300320 ↗
82. Synthesis and reactivities of 3-Indocyanine-green-acyl-1,3-thiazolidine-2-thione (ICG-ATT) as a new near-infrared fluorescent-labeling reagent10.1016/S0968-0896(98)00156-4 ↗
83. Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives10.1016/j.bmc.2013.12.026 ↗
84. An insight into symmetrical cyanine dyes as promising selective antiproliferative agents in Caco-2 colorectal cancer cells10.3390/molecules27185779 ↗
85. Advances on photodynamic therapy of melanoma through novel ring-fused 5,15-diphenylchlorins10.1016/j.ejmech.2017.12.093 ↗
86. Platinum(II) ring-fused chlorins as efficient Theranostic agents: dyes for tumor-imaging and photodynamic therapy of cancer10.1016/j.ejmech.2020.112468 ↗